Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.

Brey RL, Chapman J, Levine SR, Ruiz-Irastorza G, Derksen RH, Khamashta M, Shoenfeld Y.

Lupus. 2003;12(7):508-13. Review.

PMID:
12892389
2.

[Ischemic stroke with antiphospholipid antibody].

Kitagawa Y, Ohkuma H, Tokuoka K.

Brain Nerve. 2008 Oct;60(10):1144-58. Review. Japanese.

PMID:
18975602
3.

The management of stroke in antiphospholipid syndrome.

Panichpisal K, Rozner E, Levine SR.

Curr Rheumatol Rep. 2012 Feb;14(1):99-106. doi: 10.1007/s11926-011-0223-5. Review.

PMID:
22109663
4.

[Diagnosis and potential treatment of antiphospholipid syndrome-related mainly on ischemic stroke].

Okuma H, Kitagawa Y.

Brain Nerve. 2013 Nov;65(11):1319-32. Review. Japanese.

PMID:
24200610
5.

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.

Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, Shoenfeld Y.

Lupus. 2003;12(7):514-7. Review.

PMID:
12892390
6.

[Neurological aspects in antiphospholipid syndrome].

Kitagawa Y.

Rinsho Shinkeigaku. 2003 Nov;43(11):744-7. Review. Japanese.

PMID:
15152454
7.

Management of the neurological manifestations of APS--what do the trials tell us?

Brey RL.

Thromb Res. 2004;114(5-6):489-99. Review.

PMID:
15507283
8.

Management of antiphospholipid antibody syndrome: a systematic review.

Lim W, Crowther MA, Eikelboom JW.

JAMA. 2006 Mar 1;295(9):1050-7. Review.

PMID:
16507806
9.

Towards evidence-based treatment of thrombotic antiphospholipid syndrome.

Derksen RH, de Groot PG.

Lupus. 2010 Apr;19(4):470-4. doi: 10.1177/0961203309361483. Review.

PMID:
20353990
10.

Thrombotic risk in the antiphospholipid syndrome.

Lim W.

Semin Thromb Hemost. 2014 Oct;40(7):741-6. doi: 10.1055/s-0034-1390003. Epub 2014 Oct 9. Review.

PMID:
25299926
11.

Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome.

Chapman J, Shoenfeld Y.

Ann N Y Acad Sci. 2002 Jun;966:415-24. Review.

PMID:
12114299
12.

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.

Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y; Catastrophic Antiphospholipid Syndrome Registry Project Group.

Lupus. 2003;12(7):530-4. Review.

PMID:
12892393
13.

Antiphospholipid antibodies in young adults with stroke.

Brey RL.

J Thromb Thrombolysis. 2005 Oct;20(2):105-12. Review.

PMID:
16205859
14.

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.

Ruiz-Irastorza G, Hunt BJ, Khamashta MA.

Arthritis Rheum. 2007 Dec 15;57(8):1487-95. Review.

15.
16.

Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine.

Muscal E, Brey RL.

Int J Clin Pract. 2007 Sep;61(9):1561-8. Epub 2007 Jun 26. Review.

PMID:
17596187
17.

Which are the best biological markers of the antiphospholipid syndrome?

Carreras LO, Forastiero RR, Martinuzzo ME.

J Autoimmun. 2000 Sep;15(2):163-72. Review.

PMID:
10968904
18.

CNS dysfunction in the antiphospholipid syndrome.

Katzav A, Chapman J, Shoenfeld Y.

Lupus. 2003;12(12):903-7. Review.

PMID:
14714909
19.

The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review.

Sciascia S, Sanna G, Khamashta MA, Cuadrado MJ, Erkan D, Andreoli L, Bertolaccini ML; APS Action.

Ann Rheum Dis. 2015 Nov;74(11):2028-33. doi: 10.1136/annrheumdis-2014-205663. Epub 2014 Jun 18. Review.

20.

Supplemental Content

Support Center